Treatment of chronic proteinuric kidney disease: what next?
Benigni
Ariela
A
Remuzzi
Giuseppe
G
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001158:Arteries / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D004359:Drug Therapy, Combination; D065128:Endothelin Receptor Antagonists; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000627:therapeutic use*; D011507:Proteinuria / Q000503:physiopathology / Q000517:prevention & control*; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D010456:Peptides, Cyclic; C072247:cyclo(Trp-Asp-Pro-Val-Leu)